Investments (Tables)

9 Months Ended

Mar. 31, 2023

Equity Method Investments and Joint Ventures [Abstract]

Equity investments by measurement category were as follows (in thousands):


Measurement category	March 31, 2023		June 30, 2022
Fair value	$	12,115	$	9,167
Measurement alternative	70,640		39,290
Equity method	67,697		9,918
Total	$	150,452	$	58,375

Schedule of Changes in Equity Investments

The following tables show a reconciliation of the changes in our equity investments (in thousands):


	Nine Months Ended March 31, 2023
	Non-marketable securities		Marketable securities		Equity method investments		Total
Balance at the beginning of the period	$	39,290	$	9,167	$	9,918	$	58,375
Additions to investments (1)	21,738		4,991		60,233		86,962
Observable price adjustments on non-marketable equity securities	12,612		—		—		12,612
Unrealized losses on marketable equity securities	—		(2,043)		—		(2,043)
Realized gains on marketable and non-marketable equity securities	3,937		—		—		3,937
Proceeds from exits of investments	(3,937)		—		—		(3,937)
Impairment of investments	(3,000)		—		—		(3,000)
Loss attributable to equity method investments	—		—		(5,037)		(5,037)
Foreign currency translation adjustments	—		—		2,583		2,583
Carrying value at the end of the period	$	70,640	$	12,115	$	67,697	$	150,452

(1)Includes additions from purchases and an equity method investment acquired and measured at fair value via our acquisition of MEDIFOX DAN. Refer to Note 12 herein.


	Nine Months Ended March 31, 2022
	Non-marketable securities		Marketable securities		Equity method investments		Total
Balance at the beginning of the period	$	23,002	$	29,084	$	17,154	$	69,240
Net additions (reductions) to investments (2)	7,665		(3,202)		1,250		5,713
Observable price adjustments on non-marketable equity securities	5,367		—		—		5,367
Unrealized losses on marketable equity securities	—		(9,666)		—		(9,666)
Realized gains on marketable and non-marketable equity securities	2,355		1,626		—		3,981
Impairment of investments	(209)		—		—		(209)
Loss attributable to equity method investments	—		—		(5,927)		(5,927)
Carrying value at the end of the period	$	38,180	$	17,842	$	12,477	$	68,499

(2)Includes additions from purchases, reductions due to exits of securities, or reclassifications due to our acquisition of an investee in which we held a prior equity interest.